| #40 |
Douglas Walls |
Oracle |
1 |
| #40 |
Carlo Di Nallo |
Apple |
1 |
| #40 |
Ziyang Zhong |
Anwita Biosciences |
1 |
| #40 |
Mitchel Kampf |
Logitech Europe S.A. |
1 |
| #40 |
Steven delCardayre |
Maxygen |
1 |
| #40 |
David Whyte |
Sugen |
1 |
| #40 |
Wing-Cheong Liu |
Syngen |
1 |
| #40 |
Jadie Soo Sun |
Sony |
1 |
| #40 |
Vanitha Ramakrishnan-DuBridge |
Portola Pharmaceuticals |
1 |
| #40 |
David Lee |
Precision Automation |
1 |
| #40 |
David C. Bomberger |
Lipid Sciences |
1 |
| #40 |
Yu Hei Sunny Wai |
— |
1 |
| #40 |
Aleksandr Meyman |
Nevmet |
1 |
| #40 |
Norma Tom |
Pfizer |
1 |
| #40 |
Dov Zimring |
Google |
1 |
| #40 |
Tae Eun Choe |
Baidu Usa |
1 |
| #40 |
Thomas B. Ottoboni |
Heron Therapeutics |
1 |
| #40 |
Katherine J. Stephenson |
Metactive Medical |
1 |
| #40 |
Mariko Nagashima |
Daio Paper |
1 |
| #40 |
Jonathan Betts-LaCroix |
Vium |
1 |
| #40 |
Eric J. Shrader |
Palo Alto Research Center Incorporated |
1 |
| #40 |
Vincent Zammit |
Google |
1 |
| #40 |
Jonathan James Currey |
Apple |
1 |
| #40 |
David Garrett Loughhead |
Syntex (U.S.A.) |
1 |
| #40 |
Emilio Graff |
Caltech |
1 |
| #40 |
Muthu Olagappan |
Oracle |
1 |
| #40 |
Gregory M. Whited |
Danisco Us |
1 |
| #40 |
Diana K. Smetters |
Palo Alto Research Center Incorporated |
1 |
| #40 |
Serge Plotkin |
Netapp |
1 |
| #40 |
Gilbert-Andre Keller |
Diadexus |
1 |
| #40 |
Boris Klots |
Oracle |
1 |
| #40 |
Chin-Shiou Huang |
Plexbio Co. |
1 |
| #40 |
Thomas E. Whittaker |
Ianywhere Solutions |
1 |
| #40 |
Min Chang |
ExxonMobil |
1 |
| #40 |
Robert Seemayer |
Gilead Sciences |
1 |
| #40 |
James Wang |
Ricoh Company |
1 |
| #40 |
Beethoven Cheng |
Oracle |
1 |
| #40 |
Vladimir Lemberg |
Visx, Incorporated |
1 |
| #40 |
Timothy Robertson |
Proteus Digital Health |
1 |
| #40 |
Tolga Bozkaya |
Google |
1 |
| #40 |
Eric Goldfarb |
Acclarent |
1 |
| #40 |
Michael Singer |
Heartflow |
1 |
| #40 |
Bradley R. Gunn |
Varian |
1 |
| #40 |
Neema Jalali |
Oracle |
1 |
| #40 |
Lalitha Ganti |
Oracle |
1 |
| #40 |
Matthew Spuller |
Applied Materials |
1 |
| #40 |
Ulrica Tam |
Cisco |
1 |
| #40 |
Charles E. Claycomb |
— |
1 |
| #40 |
Frank R. Holden |
Glaxo Wellcome |
1 |
| #40 |
Mark J. Nohr |
Fyre Storm |
1 |